Imatinib-associated hyperpigmentation of the palate in post-HSCT patient

Journal of Cranio-Maxillofacial Surgery

Volumn 40, Issue 5, 2012, Pages

  Resende, Renata Gonçalves ^a   Teixeira, Raissa Gabriela Lopes ^a   Vasconcelos, Fabiana De Oliveira ^a   Silva, Maria Elisa De Souza ^a   Abreu, Mauro Henrique Guimarães ^a   Gomez, Ricardo Santiago ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Hematopoietic stem cell transplant; Imatinib mesylate; Oral pigmentation

Indexed keywords

IMATINIB;

ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DIFFERENTIAL DIAGNOSIS; EAR LOBE; HARD PALATE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERPIGMENTATION; MALE; NOSE; PALATE DISEASE;

ADULT; ANTINEOPLASTIC AGENTS; EAR DISEASES; EAR, EXTERNAL; FACIAL DERMATOSES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPERPIGMENTATION; MALE; MAXILLARY DISEASES; NEOPLASMS, SECOND PRIMARY; NEUROFIBROMATOSIS 1; NOSE DISEASES; PALATE, HARD; PIPERAZINES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEIN-TYROSINE KINASES; PYRIMIDINES; TISSUE CONDITIONING (DENTAL);

EID: 84862765606     PISSN: 10105182     EISSN: 18784119     Source Type: Journal    
DOI: 10.1016/j.jcms.2011.07.010     Document Type: Article

References (30)

1. Arora B, Kumar L, Sharma A, Wadhwa J, Kochupillai V: Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate. Ann Oncol 15: 358, 2004
2. Axell T, Hedin CA: Epidemiologic study of excessive oral melanin pigmentation with special reference to the influence of tobacco habits. Scand J Dent Res 90: 434,1982
3. Bauer AJ, Stratakis CA: The lentiginoses: cutaneous markers of systemic disease and a window to new aspects of tumorigenesis. J Med Genet 42: 801, 2005
4. Buchner A, Hansen LS: Pigmented nevi of the oral mucosa: a clinicopathologic study of 32 cases and review of 75 cases from the literature. Part II. Analysis of 107 cases. Oral Surg Oral Med Oral Pathol 49: 55, 1980
5. Buchner A, Hansen LS: Pigmented nevi of the oral mucosa: a clinicopathologic study of 36 new cases and review of 155 cases from the literature. II. Analysis of 191 cases. Oral Surg Oral Med Oral Pathol 63: 676, 1987
6. Buchner A, Merrel PW, Carpenter WM: Relative frequency of solitary melanocytic lesions of the oral mucosa. J Oral Pathol Med 33: 550, 2004
7. Cunha KS, Barboza EP, Dias EP, Oliveira FM: Neurofibromatosis type I with periodontal manifestation. A case report and literature review. Br Dent J 196: 457-460, 2004 (Pubitemid 38626381)
8. Eisen D: Disorders of pigmentation in the oral cavity. Clin Dermatol 18: 579, 2000
9. Fatahzadeh M, Sirois DA: Multiple intraoral melanoacanthomas: a case report with unusual findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94: 54, 2002
10. Femiano F, Lanza A, Buonaiuto C, Gombos F, Di Spirito F, Cirillo N: Oral malignant melanoma: a review of the literature. J Oral Pathol Med 37: 383, 2008
11. Gaeta GM, Satriano RA, Baroni A: Oral pigmented lesions. Clin Dermatol 20: 286, 2002
12. Geist JR, Gander DL, Stefanac SJ: Oral manifestations of neurofibromatosis types I and II. Oral Surg Oral Med Oral Pathol 73: 376, 1992
13. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, et al: A serine/threonine kinase gene defective in PeutzeJeghers syndrome.Nature 391: 184,1998
14. Kaugars GE, Heise AP, Riley WT, Abbey LM, Svirsky JA: Oral melanotic macules. A reviewof 353 cases. Oral Surg OralMedOral Pathol Oral Radiol Endod 76: 59,1993
15. Kauzman A, Pavone M,BlanasN, Bradley G: Pigmented lesions of the oral cavity: review, differential diagnosis, and case presentation. J Can Dent Assoc 70: 682, 2004
16. Kim HW: Generalized oral and cutaneous hyperpigmentation in Addison's disease. Odontostomatol Trop 11: 87, 1988
17. Kleinegger CL, Hammond HL, Vincent SD, Finkelstein MW: Acquired tufted angioma: a unique vascular lesion not previously reported in the oral mucosa. Br J Dermatol 142: 794, 2000
18. Krutchik AN, Buzdar AU: Pigmentation of the tongue and mucous membranes associated with cancer chemotherapy. South Med J 72: 1615, 1979
19. Lammie A, Drobnjak M, Gerald W, Saad A, Cote R, Cordon-Cardo C: Expression of ckit and kit ligand proteins in normal human tissues. J Histochem Cytochem 42: 1417-1425, 1994 (Pubitemid 24338014)
20. Legros L, Cassuto JP, Ortonne JP: Imatinib mesylate (Glivec): a systemic depigmenting agent for extensive vitiligo? Br J Dermatol 153: 691, 2005
21. Lenane P, Powell FC: Oral pigmentation. J Eur Acad Dermatol Venereol 14: 448, 2000
22. Lerman MA, Karimbux N, Guze KA, Woo SB: Pigmentation of the hard palate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107: 8-12, 2009
23. Lewis DM: Diffuse pigmentation of the palate. J Okla Dent Assoc 100: 24, 2009
24. Lippard VW, Kauer G: Pigmentation of palate and sublingual tissues associated with suppressive quinacrine hydrochloride therapy. AM J Trop Med 25: 469, 1945
25. Mcpherson T, Sherman V, Turner R: Imatinib-associated hyperpigmentation, a side effect that should be recognized. J Eur Acad Dermatol Venereol 23: 82, 2009
26. Meleti M, Vescovi P,Mooi WJ, van derWaal I: Pigmented lesions of the oralmucosa and perioral tissues: a flow-chart for the diagnosis and some recommendations for the management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105: 606, 2008
27. Pinto A, Raghavendra S, Lee R, DeRossi S, Alawi F: Epitheloid blue nevus of the oral mucosa: a rare histologic variant. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96: 429, 2003
28. Scofield HH: The blue (JadassohneTieche) nevus: a previously unreported intraoral lesion. J Oral Surg 17: 4, 1959
29. Susser WS, Whitaker-Worth DL, Grant-Kels JM: Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 40: 367, 1999
30. Valeyrie L, Bastuji-Garin S, Revuz J, Bachot N, Wechsler J, Berthaud P, et al: Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients. J Am Acad Dermatol 48: 201-206, 2003 (Pubitemid 36232317)